跳至主要内容
临床试验/IRCT20221112056476N1
IRCT20221112056476N1招募中1 期

Evaluation of the effectiveness of Curcumin in the improving patients with autoimmune hepatitis

Zahedan University of Medical Sciences0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Age range from 18 to 50 years
  • Suffering from autoimmune hepatitis based on diagnostic criteria (abnormalities of AST and ALT levels, hypergammaglobulinemia and increased serum IgG levels), positive serological findings (SMA, ANA and anti-LKM1) and histological findings and confirmed by an adult gastroenterologist

排除标准

  • 未提供

研究者

发起方
Zahedan University of Medical Sciences

相似试验